The Senate Fumbles its First Stab at Pharma Profiteering, Keeping the Issue Front and Center in 2017
Endpoints News assesses the big biopharma R&D story this week in a special year-end sendoff. Chances are, this is also what we’ll be talking about in 2017. And it will certainly be front and center at the upcoming J.P. Morgan Healthcare Conference.